Participant flow

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients · Source last updated 2019-01-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Fluzone High dose vaccine administered at Day 0. Fluzone High dose vaccine administered as a booster after 30 days from the initial vaccine. Fluzone High Dose Vaccine

   id

   FG000

   title

   Fluzone High Dose Vaccine Then Fluzone High Dose Booster

2. description

   Fluzone High-Dose if age greater than or equal to 65 or Standard dose influenza vaccine if age less than 65 at day 0. Placebo administered 30 days after the initial vaccine. Standard of care/Placebo

   id

   FG001

   title

   Standard of Care

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         81

      2. group Id

         FG001

         num Subjects

         41

      comment

      Initial Vaccine

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         19

      2. group Id

         FG001

         num Subjects

         12

      comment

      Research blood draw only

      type

      Day 7 (+/- 2 Days) (Optional)

   3. achievements

      1. group Id

         FG000

         num Subjects

         74

      2. group Id

         FG001

         num Subjects

         41

      comment

      30 Days After Initial Vaccine

      type

      Day of Second Vaccine

   4. achievements

      1. group Id

         FG000

         num Subjects

         72

      2. group Id

         FG001

         num Subjects

         35

      comment

      30 Days After Second Vaccine

      type

      30 Days Following 2nd Vaccine

   5. achievements

      1. group Id

         FG000

         num Subjects

         38

      2. group Id

         FG001

         num Subjects

         18

      type

      End of Study Visit (Optional)

   6. achievements

      1. group Id

         FG000

         num Subjects

         72

      2. group Id

         FG001

         num Subjects

         35

      comment

      All Required Milestones

      type

      COMPLETED

   7. achievements

      1. group Id

         FG000

         num Subjects

         9

      2. group Id

         FG001

         num Subjects

         6

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice